Pressure BioSciences

Easton, United States Founded: 1978 • Age: 48 yrs
Biomolecular reactions are controlled via pressure cycling technology.
Request Access

About Pressure BioSciences

Pressure BioSciences is a company based in Easton (United States) founded in 1978.. Pressure BioSciences has completed 4 acquisitions, including BaroFold, CannaWorx and CannaWorx. Pressure BioSciences offers products and services including BaroShear TM K45, Barocycler 2320EXT, and Barofold TM. Pressure BioSciences operates in a competitive market with competitors including Evosep, Ovizio, Curiox, inveox and AcouSort, among others.

  • Headquarter Easton, United States
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pressure Biosciences, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
    $1.98 M
    14.36
    as on Dec 31, 2023
  • Net Profit
    $-29.31 M
    -82.34
    as on Dec 31, 2023
  • EBITDA
    $-9.39 M
    -101.3
    as on Dec 31, 2023
  • Latest Funding Round
    $10 M (USD), Post-IPO

    Mar 01, 2023

  • Investors
    NIH

    & 1 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
    BaroFold

    & 3 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Pressure BioSciences

Pressure BioSciences is a publicly listed company on the OTC with ticker symbol PBIO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: OTC · Ticker: PBIO . Sector: Health technology · USA

Products & Services of Pressure BioSciences

Pressure BioSciences offers a comprehensive portfolio of products and services, including BaroShear TM K45, Barocycler 2320EXT, and Barofold TM. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for efficient preparation of high-quality water-soluble nanoemulsions.

Compact bench-top tool for simultaneous high-pressure sample processing.

High-pressure system for refolding proteins in life sciences research.

People of Pressure BioSciences
Headcount 10-50
Employee Profiles 7
Employee Profiles
People
Richard T. Schumacher
President, & CEO
People
Gary Smejkal
Senior Research Scientist
People
Ken Micciche
Director of Business Development
People
Alexander Lazarev
Chief Science Officer

Unlock access to complete

Funding Insights of Pressure BioSciences

  • Total Funding
  • Total Rounds 24
  • Last Round Post-IPO — $10.0M
  • First Round

    (15 Sep 2006)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2023 Amount Post-IPO - Pressure BioSciences Valuation

investors

Mar, 2019 Amount Post-IPO - Pressure BioSciences Valuation

investors

Nov, 2016 Amount Post-IPO - Pressure BioSciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Pressure BioSciences

Pressure BioSciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Pressure BioSciences

Pressure BioSciences has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include BaroFold, CannaWorx and CannaWorx. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
FDA-cleared cannabis products are provided for medical and wellness uses.
2019
Brand of natural beauty and personal care products
2018
Cannabis solutions are developed and provided by Cannaworx.
2014
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Pressure BioSciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pressure Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Pressure BioSciences

Pressure BioSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evosep, Ovizio, Curiox, inveox and AcouSort, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Solutions for clinical proteomics sample preparation are developed.
domain founded_year HQ Location
Imaging systems and AI software for microscopes are developed.
domain founded_year HQ Location
Wall-less plates and washers are developed for automated cell-based assays.
domain founded_year HQ Location
Automated solutions for biopsy sample preparation in laboratories are provided.
domain founded_year HQ Location
Microfluidic acoustofluidics technology for cell separation is developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pressure Biosciences

Frequently Asked Questions about Pressure BioSciences

When was Pressure BioSciences founded?

Pressure BioSciences was founded in 1978 and raised its 1st funding round 28 years after it was founded.

Where is Pressure BioSciences located?

Pressure BioSciences is headquartered in Easton, United States.

What is the annual revenue of Pressure BioSciences?

Annual revenue of Pressure BioSciences is $1.98M as on Dec 31, 2023.

What does Pressure BioSciences do?

Pressure BioSciences was founded in 1978 and is headquartered in Easton, United States. Operations focus on biotechnology, where a platform technology is employed to manage biomolecular interactions. Proprietary pressure cycling technology (PCT) applies cycles of hydrostatic pressure from ambient to ultra-high levels exceeding 35,000 psi. This approach supports applications in biomarker discovery, drug development, and forensics.

Who are the top competitors of Pressure BioSciences?

Pressure BioSciences's top competitors include Ovizio, Curiox and Evosep.

What products or services does Pressure BioSciences offer?

Pressure BioSciences offers BaroShear TM K45, Barocycler 2320EXT, and Barofold TM.

Is Pressure BioSciences publicly traded?

Yes, Pressure BioSciences is publicly traded on OTC under the ticker symbol PBIO.

How many acquisitions has Pressure BioSciences made?

Pressure BioSciences has made 4 acquisitions, including BaroFold, CannaWorx, and CannaWorx.

Who are Pressure BioSciences's investors?

Pressure BioSciences has 2 investors. Key investors include NIH, and HHS.

What is Pressure BioSciences's ticker symbol?

The ticker symbol of Pressure BioSciences is PBIO on OTC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available